The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial

Table 5

Comparison of serum Ach, AchE, Hcy, and hs-CRP levels after treatment in the two groups.

Index		GLJC group (n = 37)	Ginkgo group (n = 45)	value
Ach (pg/mL)	Before treatment	135.63 (95.32–224.60)	130.84 (85.84–200.94)	0.783
	24-week treatment	258.35 (236.61–304.61)	230.74 (191.10–284.93)	0.007
AchE (pg/mL)	Before treatment	291.85 (264.54–348.78)	305.24 (270.62–371.81)	0.418
	24-week treatment	242.39 (204.79–279.07)	251.40 (233.75–275.45)	0.222
Hcy (μmol/L)	Before treatment	12.62 (3.06)	11.80 (2.57)	0.187
	24-week treatment	5.82 (1.26)	6.49 (1.13)	0.013
hs-CRP (mg/L)	Before treatment	3.59 (1.92–4.98)	3.50 (2.55–5.17)	0.830
	24-week treatment	0.76 (0.33–1.72)	0.57 (0.31–1.68)	0.867

Note: significant effect (). Normally distributed data are expressed as mean (SD), whereas nonnormally distributed data are expressed as median (IQR).